查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
下一代測序資訊學市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機遇和預測，按產品和服務、應用程式、最終用戶、地區細分
市場調查報告書
商品編碼
1342707

下一代測序資訊學市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機遇和預測，按產品和服務、應用程式、最終用戶、地區細分

Next Generation Sequencing Informatics Market-Global Industry Size, Share, Trends, Competition, Opportunity, & Forecast, 2018-2028 Segmented By Products & Services, Application, End User, Region
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

由於癌症患病率不斷上升以及下一代測序 (NGS) 臨床應用的增加，預計全球下一代測序 (NGS) 資訊學市場在 2024-2028 年預測期內將出現令人印象深刻的成長。根據全球癌症觀察站的數據，2020 年，全球報告了約 19,292,789 例新癌症病例。乳腺癌、肺癌、結直腸癌、前列腺癌和胃癌是 2020 年報告的最常見的癌症病例。此外，DNA 測序樣本數量的增加，通過使用下一代測序降低了 DNA 測序的成本（ NGS）資訊學、各種政府舉措、不斷增加的臨床應用、下一代測序（NGS）取代微陣列技術是促進市場成長的其他因素。

慢性病患病率上升

在全球範圍內，癌症是導致死亡的主要原因。根據世界衛生組織的數據，過去五年，全球報告了約 50,550,287 例癌症病例。這是由於存在物理致癌物（如紫外線和電離輻射）、化學致癌物（如石棉、煙草煙霧、酒精、黃曲霉毒素（一種食品污染物）和砷（一種飲用水污染物））以及生物致癌物（如寄生蟲感染和不健康物質）而導致的。生活方式的選擇。當今醫療保健的一個主要問題是癌症。對新型癌症療法的需求預計將推動全球下一代測序（NGS）資訊學市場的擴張。

同樣，愛滋病毒、人類乳突病毒和結核病等致命且需要潛在治療的新型病毒性疾病的日益流行，預計將進一步推動全球下一代測序（NGS）資訊學市場的成長。截至 2021 年，全球約有 3840 萬人感染愛滋病毒。

下一代測序 (NGS) 臨床研究的增加

臨床研究是由兩個組成部分組成的醫學研究：觀察性研究和臨床試驗。臨床研究活動通過下一代測序（NGS）識別病毒基因組序列，從而保護人類健康。下一代測序（NGS）技術在研究病毒基因組突變及其對人類健康的影響方面發揮著至關重要的作用。根據 2020 年《臨床組學》(Clinical OMICS) 上發表的一篇研究文章，大約 84,000 個冠狀病毒病毒基因組序列已上傳到全球共享所有流感數據計劃 (GISAID)。此外，全基因組和轉錄組測序、宏基因組學等應用程式用於不同微生物樣本的表徵，這反過來有望推動全球下一代測序（NGS）資訊學市場的成長。

DNA 微陣列技術的替代

隨著最近的進步和測序成本的大幅下降，下一代測序（下一代測序（NGS））的普及度直線上升。隨著成本變得越來越低，方法變得更簡單和更廣泛，研究人員正在選擇下一代測序（NGS）而不是微陣列來進行更多的基因組應用。此外，下一代測序 (NGS) 有可能提供更高解析度和更全面的基因組視圖。

這清楚地表明，全球正在開展大量研發活動，利用下一代測序（NGS）測序來治療人類健康，從而支持全球下一代測序（NGS）資訊學市場的成長。

可用的客製化

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（存儲和計算工具、商業數據分析、數據解釋和報告工具、下一代測序 (NGS) 資訊學服務、實驗室資訊管理系統 (LIMS)）
    • 按應用（藥物發現、基因篩查、疾病診斷等）
    • 按最終用戶（醫院和診斷中心、製藥和生物技術公司、學術和研究機構）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按地區

第 6 章：北美下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞

第 9 章：南美洲下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲下一代測序 (NGS) 資訊學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 阿拉伯聯合大公國下一代測序 (NGS) 資訊學
    • 沙烏地阿拉伯下一代測序 (NGS) 資訊學
    • 南非下一代測序 (NGS) 資訊學
    • 土耳其下一代測序 (NGS) 資訊學
    • 埃及下一代測序 (NGS) 資訊學

第 11 章：市場動態

  • 動力
    • 慢性病患病率上升
    • 下一代測序 (NGS) 臨床研究的增加
    • DNA 微陣列技術的替代

第 12 章：挑戰

    • 缺乏訓練有素的臨床人員來進行下一代測序 (NGS) 實驗
    • 全球範圍內下一代測序 (NGS) 的報銷率較低

第 13 章：市場趨勢與發展

第14章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • SOPHiA GENETICS SA
    • Precigen, Inc.
    • QIAGEN NV
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Eagle Genomics Limited
    • BGI Genomics Co., Ltd.

第 15 章：戰略建議

簡介目錄
Product Code: 15017

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.

The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.

Rise in Prevalence of Chronic Diseases

Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.

Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

Increase in Clinical Research for Next Generation Sequencing (NGS)

Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

Substitution of DNA Microarray Technology

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.

This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

Market Segmentation

Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

Company Profiles

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Report Scope

In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Products & Services:

  • Storage and Computing Tools
  • Commercial Data Analysis
  • Data Interpretation, and Reporting Tools
  • Next Generation Sequencing (NGS)
  • Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis
  • Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
    • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
    • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Products & Services
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Country
    • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Products & Services
        • 10.3.4.2.2. By Application
    • 10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Products & Services
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rise in Prevalence of Chronic Diseases
    • 11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
    • 11.1.3. Substitution of DNA Microarray Technology

12. Challenges

    • 12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
    • 12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
    • 14.5.1. Abbott Laboratories, Inc.
    • 14.5.2. F. Hoffmann-La Roche Ltd.
    • 14.5.3. PerkinElmer, Inc.
    • 14.5.4. SOPHiA GENETICS SA
    • 14.5.5. Precigen, Inc.
    • 14.5.6. QIAGEN N.V.
    • 14.5.7. Illumina, Inc.
    • 14.5.8. Agilent Technologies, Inc.
    • 14.5.9. Eagle Genomics Limited
    • 14.5.10. BGI Genomics Co., Ltd.

15. Strategic Recommendations